Development of a Novel Human Single Chain Antibody Against EGFRVIII
Antigen by Phage Display Technology

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology

Purpose: EGFRvIII as the most common mutant variant of the epidermal growth factor receptor is resulting from deletion of exons 2–7 in the coding sequence and junction of exons 1 and 8 through a novel glycine residue. EGFRvIII is highly expressed in glioblastoma, carcinoma of the breast, ovary, and...

Full description

Bibliographic Details
Main Authors:	Leila Rahbarnia, Safar Farajnia, Hossein Babaei, Jafar Majidi, Bahman Akbari, Shiva Ahdi khosroshahi
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2016-12-01
Series:	Advanced Pharmaceutical Bulletin
Subjects:	Human single chain antibody Cancer EGFRvIII Phage display
Online Access:	http://journals.tbzmed.ac.ir/APB/Manuscript/APB-6-563.pdf

Similar Items

Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2018-03-01)

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model
by: Jin Myung Choi, et al.
Published: (2022-09-01)

In Vivo Evaluation of <sup>68</sup>Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model
by: Jun Young Park, et al.
Published: (2024-06-01)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
by: You Li, et al.
Published: (2020-08-01)

Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
by: Rebecca C Abbott, et al.
Published: (2023-01-01)

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
by: Bryan D. Choi, et al.
Published: (2019-11-01)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
by: Maxime Fontanilles, et al.
Published: (2020-04-01)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
by: Meryem H. Cetin, et al.
Published: (2023-01-01)

Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
by: Tsutomu Nakazawa, et al.
Published: (2020-04-01)

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
by: Kristina Ellwanger, et al.
Published: (2017-05-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

A Rational Designed Novel Bispecific Antibody for the Treatment of GBM
by: Rui Sun, et al.
Published: (2021-06-01)

The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III
by: Wen Xu, et al.
Published: (2018-03-01)

EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma
by: Robert C. Sterner, et al.
Published: (2024-09-01)

Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastoma
by: Nayuta Higa, et al.
Published: (2023-01-01)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
by: Joseph S. Durgin, et al.
Published: (2021-05-01)

The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
by: Qixue Wang, et al.
Published: (2019-10-01)

A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma
by: Ying Jiang, et al.
Published: (2023-05-01)

Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
by: Tang J, et al.
Published: (2017-05-01)

Pan‐cancer molecular analysis of EGFR large fragment deletion in the Asian population
by: Jun Pu, et al.
Published: (2023-04-01)

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
by: Laura Menotti, et al.
Published: (2018-06-01)

Phage display technology: applications and innovations
by: Marco Antonio Arap
Published: (2005-03-01)

Phage Display of Combinatorial Peptide Libraries: Application to Antiviral Research
by: Bernadette Heyd, et al.
Published: (2011-04-01)

Landscape Phage: Evolution from Phage Display to Nanobiotechnology
by: Valery A. Petrenko
Published: (2018-06-01)

Antibody Identification for Antigen Detection in Formalin-Fixed Paraffin-Embedded Tissue Using Phage Display and Naïve Libraries
by: Célestine Mairaville, et al.
Published: (2021-01-01)

Bioinformatics Resources and Tools for Phage Display
by: Ping Dai, et al.
Published: (2011-01-01)

Basics of Antibody Phage Display Technology
by: Line Ledsgaard, et al.
Published: (2018-06-01)

Ricin Detection Using Phage Displayed Single Domain Antibodies
by: Ellen R. Goldman, et al.
Published: (2009-01-01)

WSP from “Nostoc commune” Vauch. suppresses gastric cancer migration via EGFRVIII signaling
by: Xiaoxia Chen, et al.
Published: (2022-12-01)

Optimization of phage display technology for obtaining antibodies specific to tetracycline
by: Martynenko, Anzhelika V., et al.
Published: (2024-05-01)

Selection and characterization of peptides mimetic to Campylobacter fetus subsp. venerealis using phage display
by: Eduardo Lara Ribeiro, et al.
Published: (2021-06-01)

In silico analysis for identification of tick phagotopes selected by phage-displayed libraries Análises in sílico na identificação de fagotopos de carrapatos selecionados por bibliotecas de phage display
by: Carlos Roberto Prudencio, et al.
Published: (2009-03-01)

Advancement in the development of single chain antibodies using phage display technology
by: Xiaohui Zheng, et al.
Published: (2024-04-01)

Phage Display Technology as a Powerful Platform for Antibody Drug Discovery
by: Kazuya Nagano, et al.
Published: (2021-01-01)

Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides
by: Mallika C. Asar, et al.
Published: (2020-05-01)

Generation of a Biotin-Tagged Dual-Display Phage
by: Laura Maria De Plano, et al.
Published: (2024-10-01)

Phage Therapy: Past، Present and Future
by: Farzaneh Fathi, et al.
Published: (2025-02-01)

Editorial: Phage display: Technique and applications
by: Jian Huang, et al.
Published: (2022-12-01)